Tuesday - April 07, 2026

Category Archives: Professional Services

Butterly and LCG Foods Distribution Launch Three-Year Partnership to Help Canada’s Better-for-You Brands Build Consumer Trust and Drive Sales

Butterly × LCG Foods Distribution New LCG Foods x Butterly program gives Canada’s founder-led food and beverage brands access to authentic consumer reviews, high-quality social content, and peer-driven social proof that converts shelf presence into sales. TORONTO, ON – April … Continue reading →

Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Regeneron Pharma, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap, Pfizer

The Key Eosinophilic Esophagitis Companies in the market include – Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others. DelveInsight’s “Eosinophilic Esophagitis Market Insights, Epidemiology, and … Continue reading →

Epilepsy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharma, SK Biopharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The … Continue reading →

Hidradenitis Suppurativa Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | InflaRx, Novartis, UCB, AbbVie, Pfizer, Amgen, Incyte Corp, CSL

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hidradenitis Suppurativa pipeline constitutes 24+ key companies continuously working towards developing 24+ Hidradenitis Suppurativa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Non-Cystic Fibrosis Bronchiectasis Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi Farmaceutici, SolAeroMed

The Key Non-Cystic Fibrosis Bronchiectasis Companies in the market include – Boehringer Ingelheim, Zambon, Insmed, AstraZeneca, Zambion, The Marcus Foundation, Inc., Chiesi Farmaceutici S.p.A., SolAeroMed Inc., Zambon SpA, Boehringer Ingelheim, Renovion, Inc., Novartis, Alaxia SAS, and others. DelveInsight’s “Non-Cystic Fibrosis … Continue reading →

Oncolytic Virus Therapies Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | CG Oncology, Imugene, Amgen, Daiichi Sankyo, Genelux, Replimune, Binhui Biopharma

The Key Oncolytic Virus Therapies Companies in the market include – CG Oncology, Imugene, Amgen, Daiichi Sankyo, Genelux, Replimune, Binhui Biopharmaceutical, Zhejiang Cancer Hospital, and others. DelveInsight’s report “Oncolytic Virus Therapies Market Insights, Epidemiology, and Market Forecast-2034,” provides a comprehensive … Continue reading →